A New Weapon in the Fight against HIV/TB Co-Infection

By on .

New results from a tuberculosis vaccine trial indicate that the Mycobacterium vaccae (MV) was effective in preventing TB among people with HIV. Given that TB is the No. 1 killer of people with HIV in the developing world, this could be a major advance in the battle against these synergistic scourges.

In the seven-year study in Tanzania, researchers with Dartmouth University and other partner institutions found that immunization with MV reduced the rate of TB by 39 percent. Now, they said, the focus needs to turn to manufacturing larger amounts of the vaccine for additional studies and possible clinical use.

Click here to read the Dartmouth press release and here to read a news story about the trial findings.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.